Patent Baristas

If you let go of trying to get more of what you don’t really need, it frees up oceans of energy to make a difference with what you have. When you make a difference with what you have, what you have expands.
~ Lynne Twist on the principle of sufficiency
As we go through a season of [...]

We’re back again this year with a list of the best gifts for patent geeks and entrepreneurs.  We thought that No. 1 on our list would be the Apple Mystery Tablet but it’s still a no-show.  And, no, we’re not going to recommend the $1800 UWCP Underwater Cellular Phone System from OceanReef (see the bizarre [...]

Pfizer is continuing its fight with generic drug manufacturer United Laboratories, Inc. (Unilab)in the Philippines over the issue of the validity of the patent on Lipitor (atorvastatin) as Unilab tries to have the patent canceled. Unilab filed its petition for the cancellation of Philippine Patent No. 29149 for Atorvastatin, marketed under the brand name Lipitor, [...]

gray market n. a market employing irregular but not illegal methods; especially : a market that legally circumvents authorized channels of distribution to sell goods at prices lower than those intended by the manufacturer.
~Merriam-Webster’s Dictionary of Law
A gray market (or grey market) is the trade of a commodity through distribution channels which, while legal, are [...]

“I really don’t think they have thought this through. A world without intellectual property rights would be a pretty horrible place to live. There would be no investment in new technologies.”
~Michael Taylor of CIED
The European Patent Office (EPO) is studying the growth in eco-innovation since the introduction of the Kyoto Protocol on climate change.  Although [...]

In a case highlighting the importance of ensuring a correct chain of title when filing a patent application, the UK High Court addressed the issues of loss of priority due to an incomplete assignment, as well as the credibility of expert witnesses.  In particular, it is important to transfer rights to interests initially owned by [...]

I aim to shed light on the extent to which advance in the life sciences was directed by the profit motive and the availability of the patent system … and on the ways that the patent ‘institution’ evolved in response to science and to interest groups, mainly business ones, but also legal practitioners associated with [...]

Does Patent Reform Need Congressional Action?
The Coalition for Patent Fairness (CPF) has put out a memo trying to debunk what it sees as the myth that patent reform no longer requires congressional action.  From CPF:   “The Court’s ability to effect needed changes is limited because it is restricted by the language Congress enacted more than [...]